List of insiders holdings for Third Harmonic Bio Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner | 2024-11-05 18:26:23 | 9,808,190 0 | 9,808,190 | Form 13D |
| Atlas Venture Fund XI L.P. 10% Owner | 2024-11-05 18:26:23 | 9,808,190 0 | 9,808,190 | Form 13D |
| ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC Director 10% Owner | 2024-11-12 18:04:36 | 5,779,071 0 | 5,779,071 | Form 13D |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 2024-11-12 17:27:46 | 2,372,933 0 | 2,372,933 | Form 13G |
| Holles Natalie C. CEO | 2024-05-10 16:04:44 | 1,652,690 0 | 1,652,690 | Form 4 |
| Ho Robert Chief Financial Officer | 2023-03-08 16:58:48 | 598,955 0 | 598,955 | Form 4 |
| Ray Adrian S. Chief Scientific Officer | 2023-03-08 16:58:02 | 536,871 0 | 536,871 | Form 4 |
| Murphy Christopher M. Chief Financial & Bus. Officer | 2024-01-09 16:05:02 | 410,000 0 | 410,000 | Form 4 |
| Conner Edward R. Chief Medical Officer | 2024-11-12 17:08:24 | 368,918 0 | 368,918 | Form 4 |
| Person Julie CHIEF ADMINISTRATIVE OFFICER | 2024-09-20 17:35:27 | 321,421 0 | 321,421 | Form 4 |
| Dinsmore Christopher Chief Scientific Officer | 2024-06-28 16:52:31 | 297,000 0 | 297,000 | Form 4/A |
| Dean Dennis Chief Nonclinical Dev. Officer | 2024-05-20 16:31:03 | 210,000 0 | 210,000 | Form 4 |
| MCDONOUGH GEOFF Director | 2024-03-28 16:10:32 | 60,000 0 | 60,000 | Form 4 |
| Bonita David P Director | 2024-06-10 16:20:03 | 20,000 0 | 20,000 | Form 4 |
| Gladstone Michael Director 10% Owner | 2024-06-10 16:21:15 | 20,000 0 | 20,000 | Form 4 |
| Soloway Thomas P Director | 2024-06-10 16:22:32 | 20,000 0 | 20,000 | Form 4 |
| Seidel Hans Martin Director | 2024-06-10 16:23:36 | 20,000 0 | 20,000 | Form 4 |
| Iwicki Mark T Director | 2024-06-10 16:24:33 | 20,000 0 | 20,000 | Form 4 |
| Dittman Jennifer Chief Development Oper Officer | 2024-06-10 16:26:03 | 16,294 0 | 16,294 | Form 4 |
| PEREZ ROBERT J Director | 2023-03-08 17:06:06 | 13,667 0 | 13,667 | Form 4 |
| Lin Shao-Lee Director | 2022-10-27 16:57:11 | 13,667 0 | 13,667 | Form 4 |